skip to content

Siti Asfijah Abdoellah

  • Siti Asfijah Abdoellah
  • Head, Sub-Directorate of Surveillance and Risk Analysis of Therapeutic Products National Agency of Drug and Food Control (NADFC)
    • Session 2 > Issues and Challenges - Regulatory’s Perspective [Indonesia] (Speaker)
    • Session 3 (Co-Chair)

Young-Jin Ahn

  • Young-Jin Ahn
  • Deputy Director, Drug Information Evaluation TF Team
  • Pharmaceutical Safety Bureau, Ministry of Food and Drug Safety (MFDS)
    • Session 2 > Readout of the Survey - Results from Pharmacovigilance Questionnaire of APEC RHSC (Speaker)

AHC Noimage

  • Maria Francisca Aldunate Gonzalez
  • Chief, Drug Information Section (Pharmacovigilance Sub-department)
  • National Agency of Medicines
    • Session 3 > Sharing Experiences of Pharmacovigilances (Panelist - Chile)

Cecilia Beltran

  • Cecilia Beltran
  • Pharmaceutical chemical
  • Pharmacoepidemiological and pharmacovigilance Team, DIGEMID
    • Session 3 > Sharing Experiences of Pharmacovigilances (Panelist - Peru)

Donwoong Choi

  • Donwoong Choi
  • Director, Pharmaceutical Safety Information Team
  • Ministry of Food and Drug Safety (MFDS)
    • Session 2 > Sharing Experiences of Pharmacovigilances [Korea] (Speaker)
    • Session 3 > Sharing Experiences of Pharmacovigilances (Panelist - Korea)

Nam-kyong Choi

  • Nam-kyong Choi
  • Research Professor, Medical research Collaborating Center
  • Seoul National University Hospital / Seoul National University College of Medicine
    • Session 2 > Issues and Challenges - Academia's Perspective (Speaker)

Gerald Dal Pan

  • Gerald Dal Pan
  • Director, Office of Surveillance and Epidemioogy
  • Center for Drug Evaluation and Research, US Food and Drug Administration (FDA)
    • Session 1 > Harmonization Activities on Pharmacovigilance - ICH Activities on Pharmacovigilance (Speaker)
    • Session 3 (Co-Chair)
    • Session 4 > Risk Communication Introduction and Current Practices (Speaker)

Jean-Christophe Delumeau

  • Jean-Christophe Delumeau
  • Head, Pharmacovigilance Asia-Pacific, Research & Development
  • Bayer HealthCare
    • Session 2 > Issues and Challenges - Industry's Perspective (Speaker)
    • Session 4 (Co-Chair)

AHC Noimage

  • Mdm. Rokiah Isahak
  • Senior Principal Assistant Director
  • Pharmacovigilance Section, Centre for registration of product
  • National Pharmaceutical Control Bureau, Ministry of Health
    • Session 3 > Sharing Experiences of Pharmacovigilances (Panelist - Malaysia)

Jin-Ho Lee

  • Jin-Ho Lee
  • Professor Division of Gastroenterology & Hepatology Department of Internal Medicine
  • Dongguk University Ilsan Hospital
    • Session 4 (Co-Chair)

Sun-Hee Lee

  • Sun-Hee Lee
  • Director General Drug Evaluation Department, National Institute of Food and Drug Safety Evaluation
  • Ministry of Food and Drug Safety (MFDS)
    • Session 2 (Co-Chair)

AHC Noimage

  • Antonio Mastroianni
  • Chief Operations Officer, Pharmacovigilance, Uppsala Monitoring Centre (UMC)
  • WHO Collaborating Centre for International Drug Monitoring
    • Session 2 (Co-Chair)
    • Session 2 > Global Leadership for the Safer Use of Medicines (Speaker)

Shanthi Narayan Pal

  • Shanthi Narayan Pal
  • Team leader (Medicines), Safety and Vigilance
  • Essential Medicines and Health Products, World Health Organization (WHO)
    • Session 1 > Harmonization Activities on Pharmacovigilance - WHO Activities on Pharmacovigilance (Speaker)

Byung Joo Park

  • Byung Joo Park
  • Professor Preventive Medicine, Seoul National University
  • President Korea Institute of Drug Safety and Risk Management (KIDS)
    • Session 1 (Co-Chair)

Jong Pil Park

  • Jong Pil Park
  • Deputy Director, Drug Information Evaluation TF Team
  • Pharmaceutical Safety Bureau, Ministry of Food and Drug Safety (MFDS)
    • Session 1 > Harmonization Activities on Pharmacovigilance - APEC Efforts on Pharmacovigilance and Overview of Pharmacovigilance Roadmap (Speaker)

Ola Strandberg

  • Ola Strandberg
  • Chief Product Officer
  • Uppsala Monitoring Centre, WHO Collaborating Centre of International Drug Monitoring
    • Session 3 > Sharing Experiences of Pharmacovigilances (Panelist - UMC)

Wimon Suwankesawong

  • Wimon Suwankesawong
  • Head, Health Product Vigilance Center
  • Thai Food and Drug Administration
    • Session 1 (Co-Chair)
    • Session 2 > Issues and Challenges - Regulatory’s Perspective [Thailand] (Speaker)
    • Session 3 > Sharing Experiences of Pharmacovigilance (Panelist - Thailand)

Ian Chi Kei Wong

  • Ian Chi Kei Wong
  • Head, Pharmacology and Pharmacy
  • The University of Hong Kong / ISoP
    • Session 1 > Harmonization Activities on Pharmacovigilance ? Academia’s Activities on Pharmacovigilance (Speaker)

Moo-Young Yoo

  • Moo-Young Yoo
  • Director General, Pharmaceutical Safety Bureau
  • Ministry of Food and Drug Safety(MFDS)
    • Keynote Speech > Driving Pharmacovigilance Success

Li Zhang

  • Li Zhang
  • Professor, Department of ADR monitoring, Center for Drug reevaluation (National Center for ADR monitoring)
  • China Food and Drug Administration (CFDA)
    • Session 2 > Issues and Challenges - Regulatory’s Perspective [China] (Speaker)
    • Session 3 > Sharing Experiences of Pharmacovigilances (Panelist - China)